Skip to content

Orthofix Medical Inc. OFIX Contingent consideration fair value adjustments

Contingent consideration fair value adjustments at other companies

Boston Scientific logo
Boston ScientificBSX
-$30M-700%
Globus Medical logo
Globus MedicalGMED
Enovis logo
EnovisENOV
Artivion logo
ArtivionAORT
IAR
Integra LifeSciencesIART
Merit Medical Systems logo
Merit Medical SystemsMMSI

Other financials

Income statement

See full
Revenue$196.7M+1.6%
Gross profit$139.5M+14.7%
Operating income-$14.4M+70.5%
Net income-$20.9M+60.6%
EPS (diluted)-$0.52+61.5%

Balance sheet

See full
Cash & equivalents$120.3M+108%
Total debt$237.5M+32.3%
Total equity$435.2M-5.0%
Total assets$886.6M+7.7%

Cash flow

See full
Operating cash flow-$17.6M+4.2%
CapEx$10.7M+58.3%
Free cash flow-$28.3M-12.5%

Valuation

See full
Market cap$376.33M-7.1%
Enterprise value$493.54M-6.3%
P/S0.5×0.0×

Profitability

See full
Gross margin70.7%+3.6pp
Operating margin-5.8%-2.1pp
Net margin-7.3%-2.7pp
FCF margin-9.3%-1.7pp

Returns & leverage

See full
Return on equity-13.4%-4.6pp
Debt / equity0.5×+0.2×
Current ratio2.9×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: Orthofix Medical Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Orthofix Medical Inc.'s contingent consideration fair value adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Orthofix Medical Inc.'s contingent consideration fair value adjustments?
Orthofix Medical Inc. (OFIX) reported contingent consideration fair value adjustments of $750K in Q1 2026.
How has Orthofix Medical Inc.'s contingent consideration fair value adjustments changed year-over-year?
Orthofix Medical Inc.'s contingent consideration fair value adjustments increased by 223.0% year-over-year, from -$610K to $750K.
What is the long-term trend for Orthofix Medical Inc.'s contingent consideration fair value adjustments?
Over 3 years (2021 to 2024), Orthofix Medical Inc.'s contingent consideration fair value adjustments has grown at a 24.5% compound annual growth rate (CAGR), from -$3.58M to $6.9M.